• Post-translational modifications of the cytoplasmic domain of TF regulates its function and release.
Introduction
Precise control of the release of tissue factor (TF) as microvesicle by cells is crucial for adequate coagulation, without the risk of thrombosis. Consequently, the regulation of TF release by cells is subject to a number of mechanisms that act as positive and negative factors.
Furthermore, TF appears to have a number of cellular functions, beyond that of initiating the coagulation mechanism [1] [2] [3] . Regulation of the incorporation of TF into cell derived microvesicles and also the termination of this process, entails mechanisms that include multiple post-transcriptional modifications of the cytoplasmic domain of TF [3] [4] [5] [6] [7] [8] . The phosphorylation of TF by protein kinase c at serine 253 occurs following the depalmitoylation of the cytoplasmic domain of TF [8] and permits the recruitment of filamin A which is essential for the incorporation of TF into microvesicles [9] [10] [11] . In contrast, the delayed phosphorylation of TF at serine 258 by p38 [5] appears to eventually lead to dephosphorylation of serine 253 within TF, by phosphatase PP2A [4] . Therefore an inescapable remaining question concerns the mechanism by which cells gauge the level of TF required/released for appropriate coagulation, and shut down the release process. Interestingly, double-phosphorylation of TF creates a suitable ubiquitination site within the cytoplasmic domain of TF which in turn may promote TF dephosphorylation [6] . Furthermore, the phosphorylation of serine 258 produces a phosphoserine-proline motif (termed an MPM-2 motif) which suggest the involvement of the enzyme peptidy-prolyl trans/cis isomerase 1 (Pin1) [12] [13] [14] . This enzyme is known to alter the structure of a number of proteins with a similar motif resulting in wide-ranging outcomes [14] [15] [16] [17] including alteration in susceptibility of the target protein to dephosphorylation [16] [17] [18] [19] , ubiquitination [19, 21] as well as the function and stability of the proteins [16, [22] [23] [24] . In this study we examine the hypothesis that Pin1 is a crucial moderator which acts to regulate the termination of the release of TF, through a mechanism that is dependent on the level of TF being released and therefore, the level of cellular activation.
Materials and Methods
Cell culture and transfection, microvesicle preparation and measurement of TF mRNA, antigen and activity MDA-MB-231 cell line (ATCC, Teddington, UK) was cultured in DMEM containing 10% (v/v) foetal calf serum (FCS). Human coronary artery endothelial cells (HCAEC) were purchased and cultured in MV media containing 5% (v/v) FCS and growth supplements (PromoCell, Heidelberg, Germany). HCAEC (2×10 5 ) were transfected with 1 µg of pCMV-XL5-TF plasmid DNA (OriGene, Rockville, USA) using Lipofectin (Invitrogen, Paisley, UK) as previously described in order to express wild-type TF [4] . Cells (2×10 5 ) were seeded out in 6-well plates and pre-adapted to respective serum-free medium prior to experiments [4, 9] . To induce microvesicle release, the cells were stimulated with protease activated receptor 2-activating peptide (PAR2-AP); SLIGRL; (20 µM). The released microvesicles were then isolated from conditioned media, resuspended in phosphate-buffered saline (PBS) and assessed according to published procedures [25] . The microvesicles were quantified using the functional assay Zymuphen MP assay kit (Hyphen BioMed/Quadratech Ltd, Epsom, UK). Microvesicleassociated TF antigen and activity were measured using a TF-EIA kit and thrombin-generation assay, respectively [4, 26, 27] . Cell numbers in the samples were determined by staining with crystal violet as previously described [28, 29] . In some experiments the cells were pre-incubated Fig   1) . The expression of TF mRNA and protein in the cells as well as cell surface TF were monitored using RT-PCR, TF-EIA and flow cytometry as previously described [9, 26] . In addition, samples of cells lacking Pin1 were pre-incubated with SB202190 (50 µM) to inhibit the phosphorylation of Ser258 by p38α [5] , prior to activation.
Immunoprecipitation of TF protein
TF protein was immunoprecipitated from cell lysates using mouse or rabbit anti-human TF antibodies depending on the target analysis; a rabbit anti-human antibody (FL295) (Santa Cruz Technology, Heidelberg, Germany) (4 µg per sample) was employed when the samples were to be subsequently examined using anti-mouse antibodies by western blot. Conversely a mouse anti-TF antibody (10H10) (Santa Cruz) (4 µg per sample) was used when the western blot analysis involved anti-rabbit antibody. Appropriate IgG isotypes (Cell Signalling Technology)
were also included at identical concentrations as well as an additional control without any antibody. All samples were incubated at 4°C overnight with gentle shaking. Pureproteome protein A-magnetic beads (10 µl) (Merck-Millipore) was added to all samples and controls and incubated at 4°C for 90 min with shaking. The samples were then placed in a magnetic stand and the supernatant removed, washed five times with PBST (1 ml) and the samples denatured in SDS-PAGE loading buffer (70 µl) (Sigma).
Western blot analysis
Electrophoresis was carried out on a 12% (w/v) denaturing-polyacrylamide gel and the protein bands were transferred onto nitrocellulose membranes and blocked with TBST (10 mM
Tris-HCl pH 7.4, 150 mM NaCl, 0.05% . Western blot analysis of the samples was carried out to detect TF using FL295 antibody (when IP was carried out using 10H10 antibody) 2) . In addition ubiquitination was detected in samples immunoprecipitated with FL295 antibody, using a mouse anti-human mono/poly-ubiquitin (FK2) antibody (Enzo) diluted 1:4000 (v/v), and developed as above [6] . Phosphorylation of Ser258 was detected in samples immunoprecipitated with 10H10 antibody using a rabbit anti-phosphoserine-TF antibody (Abcam, Cambridge, UK) specific for phospho-Ser258, diluted 1:2000 (v/v) in TBST while phosphorylation of Ser253 was detected using a rabbit anti-phospho-PKC-substrate motif antibody (Cell Signalling Technology) diluted 1:2000 (v/v) in TBST buffer as previously described [4] .
Pin1 binding assay
Substrate peptides, corresponding to the last 19 amino acids of the cytoplasmic domain of TF were synthesised in biotinylated form (Biomatik, Ontario, Canada). In total 4 peptides were synthesised in non-phosphorylated, single-phosphorylated and double-phosphorylated forms and used as substrates. An additional scrambled peptide (biotin-SWGNVSKLSAPRQGVNKE) was also included alongside. The peptides (5 µM final concentration) were diluted to 100 µl with PBS and distributed (50 µl per well) in a NeutrAvidin-coated 96-well plate (Thermo Scientific, Warrington, UK) and incubated for 2 h at room temperature. The procedure was based on a variation of previously described binding assay [30] . The wells were washed four times, each time with 300 µl of PBST. HRP-conjugated recombinant Pin1 protein was diluted 1:500 (v/v) in PBST, added to wells (100 µl) and incubated for 1 h at room temperature. The wells were then washed a further four times and developed with TMB One Solution (100 µl) (Promega). Once the colour was developed the reactions were stopped by the addition of 2M sulphuric acid (50 µl) and absorptions measured at 450 nm using a plate reader. The cocnentrations of Pin1 were determined from a standard curve made using HRP-conjugated recombinant Pin1 protein. In addition, the time-course of interaction of Pin1 with the labelled penta-peptide Succ-Glu-AsnSer-Pro-Leu-pNitroanilide and Succ-Glu-Asn-phosphoSer-Pro-Leu-pNitroanilide was investigated by measuring the alteration in spectroscopic absorption of the solution using a procedure based on that described by Janowski et al [31] . Prior to the experiments the peptides (0.5 µM) were reconsituted in Tris-HCl buffer at a range of pH values ranging between 5.5-9.5.
The absorption spectra of the peptide was analysed at 260-360 nm range and the maximal change in the absorption spectrum was determined to be 315 nm (see results). The absorption spectrum of the recombinant HRP-conjugated Pin1 was also examined which was confimed not to absorb light at 315 nm (not shown). Samples (100 µl) of the peptides were in turn placed in a microcuvette, and recombinant HRP-conjugated Pin1 added (10 nM final concentration). The change in absorption at 315 nm over time was then monitored.
Determination of cellular Pin1 concentrations by ELISA
The concentrations of Pin1 protein in MDA-MB-231 cells and HCAEC (2×10 5 ) were determined using a Pin1-ELISA kit (Enzo Life Sciences, Exeter, UK) according to manufacturer's instructions. This procedure was also used to confirm the lack of Pin1 protein after knock out using siRNA as stated above.
Pin1 binding pull-down assay
A pull-down assay was carried out in a similar procedure to the binding assay with minor alterations. The procedure was carried out using cell lysate (100 µl from 2×10 5 cells) instead of recombinant Pin1-HRP and incubated for 1 h at room temperature. Following binding, the wells were washed with PBST and probed for Pin1 using the HRP-conjugated detection antibody from the Pin1-ELISA kit, as above. The concentrations of Pin1 were determined from a standard curve made using recombinant Pin1 protein from the ELISA kit. In similar experiments, the affinity purified proteins were dissolved in the electrophoresis sample buffer and analysed by western blotting, using a rabbit anti-Pin1 polyclonal antibody (GenTex-Insight Biotechnology Ltd, Wembley, UK) diluted 1:2000 (v/v) in TBST. The membranes were then developed using an alkaline-phosphatase conjugated goat anti-rabbit IgG secondary antibody, and visualised with Western blue substrate as described above.
Phosphatase assay
The phosphatase assay was carried out as previously described [6] , using the biotinylated peptides representing the 19 amino acids of the cytoplasmic domain of TF. The peptides (10 µM)
were diluted in phosphate-free Tris-HCl (50 mM) pH 7. 
Ubiquitination assay
Ubiquitination reaction was carried out as before [6] , using the E2-Screening kit Solution (100 µl) (Promega). Once the colour was developed the reactions were stopped by the addition of 2M sulphuric acid (50 µl) and absorptions measured at 450 nm using a plate reader.
Results
Prior to the study, the suppression of Pin1 using the Silencer ® siRNA in MDA-MB-231 cells was optimised ( Supplementary Fig 1) . Downregulation of Pin1 by siRNA knockdown, or deactivation using Juglone had no influence on TF mRNA or protein expression or cell surface TF exposure compared to control siRNA or cells incubated with Plumbagin. Moreover, the rate of cell proliferation was not significantly altered in cells transfected with Pin1 siRNA compared to those transfected with control siRNA ( Supplementary Fig 3) , although Pin1 is thought to interact with proteins involved in the M-phase of the cell cycle. In addition, the duration of incubation with Juglone/Plumbagin was not long enough to influence cell proliferation and cell numbers were unchanged. Therefore, these data indicate that other cellular alterations arising from Pin1 deactivation or knock-down, were not significant in the present studies.
Pin1 is required for the prolonged release of TF into microvesicles without affecting microvesicle release
Deactivation of Pin1 in MDA-MB-231 cells by incubation with Juglone, prior to the activation of the cells with PAR2-AP, reduced the release of TF within microvesicles in a Juglone-concentration dependent manner ( Fig 1A) . A similar pattern was observed in transfected HCAEC expressing TF-tGFP, but with a lower threshold ( Fig 1B) . In contrast, pre-incubation of the cells with the non-inhibiting analogue Plumbagin, or the vehicle DMSO did not alter the release of TF in either cell type. Importantly, pre-incubation of cells with Juglone did not alter the release of the microvesicles themselves (Fig 1C & 1D) . Similarly, suppression of Pin1 expression in MDA-MB-231 cells and HCAEC using specific siRNA significantly reduced the release of TF, while the control siRNA was ineffective (Fig 1E & 1F) . Moreover, the suppression of Pin1 using siRNA had no influence on microvesicle release (Fig 1G & 1H) . Finally, the inclusion of SB202190 (50 nM Ser258 by western blot analysis with maximal differences observed at 30 min (Fig 2A) . It must be noted that due to the procedure used, the immunoprecipitated TF antigen is a purified sample and may not be used to compare the amount of cellular TF in these samples. Also, since no housekeeping control is available, all comparisons were made with respect to the immunoprecipitated TF antigen levels. In the absence of Pin1 the phosphorylation of Ser253 was largely diminished at any of the time points assessed while it was clearly detectable in the control cells at 15 and 30 min (Fig 2B) . Interestingly, the phosphorylation state of Ser258 was not significantly altered following suppression of Pin1 (Fig 2C) . Similar studies using HCAEC produced only small amounts of TF probably due to double transfection procedure ( Supplementary Fig 4) and therefore were not pursued further.
Pin1 preferably interacts with Ser258-phosphorylated TF but also with doublephosphorylated form
In order to determine the preferred form of TF as a substrate for Pin1, four peptides corresponding to the 19 amino acids of the C-terminus of TF were synthesised in unphosphorylated, Ser253-phosphoryalted, Ser258-phosphorylated and double-phosphorylated.
A scrambled peptide (biotin-SWGNVSKLSAPRQGVNKE) was included. The peptide were prepared with a biotin tag and adsorbed in NeutrAvidin 96-well plates. The plates were then incubated with a range of concentrations of recombinant HRP-conjugated active Pin1, washed and the interactions detected using TMB substrate. HRP-Pin1 appeared to interact with Ser258-phosphorylated peptide preferentially and to a lesser extent with the double-phosphorylated peptide ( Fig 3A) . Interestingly, the interaction with Ser253-phosphorylated peptide was the least favourable. An attempt was made to determine the relative dissociation constants (Fig 3B &   Table 1 ). However since Pin1 may interact with peptides differently to the TF molecule, these
are relative values only, and are therefore likely to be dissimilar to the real dissociation constants values between Pin1 and TF, or the peptide motifs reported previously [32] . Similarly, incubation of the NeutrAvidin-anchored peptides with cell lysate resulted in the interaction of cellular Pin1 with the peptides (Fig 3C) which also mirrored the pattern observed using the recombinant Pin1. Interestingly, while the values were much lower than those observed with HRP-conjugated recombinant Pin1, the differences between the four peptides were more discernable when examining cellular Pin1 by pull down assay. Analysis of purified proteins by western blot showed the presence of Pin1 as faint bands with a molecular weight of around 18 kDa (Fig 3D) however, the quantity of the purified Pin1 was far too small to permit any meaningful quantification using this technique. In an attempt to determine the speed of the reaction, smaller penta-peptides corresponding to residues 256-260 (encompassing Ser258 but not Ser253) were synthesised with p-nitroanilide on the C-terminus. This procedure permits the measurement of changes in the environment of the nitroanilide by spectroscopic analysis and would indicate any interaction between Pin1 and the peptides [31] . However, the procedure is only relative and indicative, and therefore no attempt was made to derive further kinetic parameters for the interactions. The peptides were synthesised in non-phosphorylated and Ser258-phosphorylated format, and the spectra analysed at various pH values. The wavelength of maximal change was determined to be 315 nm for both peptides (Fig 3E) . Incubation of the Ser258-phosphorylated peptide with Pin1 resulted in rapid change in absorption at 315 nm and was slower in the unphosphorylated peptide ( Fig 3F) .
Pin1 can interfere with ubiquitination of TF by ubiquitin ligase complex
Suppression of Pin1 in MDA-MB-231 cells resulted in the early ubiquitination of TF ( Fig   4A) which was clearly visible at 15 min in the cells devoid of Pin1 but only became significant at 30 min in the control cells (Fig 4B) . However, the multiple banding pattern of the oligoubiquitinated TF protein was less visible than previously reported by us [6] . This was deemed to be as a consequence of the lower number of cells used in the experiments, as well as the transient nature of the TF oligoubiquitin chain which was short lived in MDA-MB-231 cells [6] . Additionally, due to immunoprecipitation procedure, the protein content analysed was a fraction of the cellular TF and not representative of the total cellular TF. Again, the amounts of recovered TF from double-transfected HCAEC were too low to determine the values reliably and are not presented. Double-phosphorylated TF peptide was ubiquitinated by the ubiquitin ligase complex containing Ube2D family of E2 ligases and Mdm2 as the E3 ligase [6] in the presence and absence of recombinant Pin1. Addition of recombinant Pin1 (1-10 nM) to the ubiquitination reaction suppressed the ubiquitination of the TF-peptide in a concentration-dependent manner (Fig 4C) . However, since the experiment was carried out under static conditions i.e. the product is not removed from the reaction, higher concentrations of Pin1 would result in the increased isomerisation in both directions and were not deemed reliable or examined further.
Pin1 can interfere with TF dephosphorylation
The inclusion of Pin1 into the reaction reduced the ability of recombinant phosphatase PP2Aα to release inorganic phosphate from the double-phosphorylated TF peptide (Fig 5A) but not the Ser253-phosphorylated peptide (Fig 5B) . Replacement of the double-phosphorylated TF peptide with a ubiquitinated form liberated a significantly higher amount of inorganic phosphate by PP2Aα (Fig 5C) but was reduced in a similar manner to the non-ubiquitinated peptide, in the presence of Pin1. Finally, to determine the potential of Pin1 to interfere with TF processing within cells, the concentration of Pin1 was measured using an ELISA system. The concentration of Pin1 was determined to be 44.8 nM ± 0.5 in MDA-MB-231 cells while the levels present in HCAEC was determined to be measured 19.3 nM ± 1.7.
Structural analysis of the outcome of Pin1-mediated isomerisation of TF
Analysis of the NMR structure of the cytoplasmic domain of TF (2CEF) [33] obtained from the databank showed that the Lys255 is present at the surface of the protein (Fig 6A) in 9 out of the 10 prevelent structures (not included). In one remaining structure, Lys255 is only partially covered by the side chain of Asn261. However, since the Asn261 appears exceptionally flexible it would not interefer with the head group of Lys255. Importantly, Lys255 appears to form hydrogen bonds with the backbone carboxy groups from Asn257, phosphoSer258 and Pro259
( Fig 6B) and to a lesser extent with the backbone carboxy group of Glu256 (Table 2 ). These interactions appear to anchor the ε-amino group of Lys255 allowing only limited movement which was found to be 4.02 Å laterally (across the protein surface), and up to 2.44 Å away from the surface of the protein, measured by calculating the greatest relative movemet of the ε-amino group betwen all 10 structures. In addition, the acyl group of Lys255 appears to be tightly secured through interaction with Trp254 with little flexibility permitted. The formation of the hydrogen bonds suggests that the protons associated with Lys255 headgroup would face away from the protein surface allowing the exposure of the nitrogen atom. Moreover, the tight control of the position of this ε-amino group indicates that it may be a suitable site for enzyme-mediated nucleopohilic interactions such as ubiquitination by ubiquitin ligases. Interestingly, isomerisation of the phosphoSer258-Pro259 peptide bond by Pin1 (Fig 6C) renders the third carboxy group (Pro259) unavailable for hydrogen bond formation with Lys255 (not shown) and therefore is likely to cause the loss of the availability of the nitrogen atom from Lys255 for amideesterification, and will hamper ubiquitination.
Discussion
Cells are known to respond to damage and stress by releasing procoagulant microvesicles which may contain TF [34] [35] [36] [37] . The release of these microvesicles from the activated cells complements the mechanisms that ensure the formation of an adequate clot and containment of the injury. However, since excessive levels of coagulation can be detrimental, it is essential that the cells can adjust the magnitude of their response to that of the injury. Consequently, cells need to detect the level of injury and gauge the amount of released TF accordingly. Moreover, once sufficient clot has been generated, the mechanism of TF release will have to be shut down rapidly. The release of TF as cell-derived microvesicles appears to be regulated though an ordered and time-dependent pathway which include post-transcriptional modifications of the cytoplasmic domain of this protein. As a result, each step permits the interaction of TF with components in the next step resulting in the release or endocytosis of TF. Consequently, there must also be factor(s) which strictly control the incorporation of TF into microvesicles and terminate the process once a "required amount of TF" has been released. One protein known to be a regulator of post-phosphorylation processes is Pin1 [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] . Normally peptide bond trans↔cis isomerisation occurs at a slow rate in nature since both of these forms are stable and the energy required for isomerisation is relatively high. However, the rotation of the peptide bond between the phosphoserine and the proline (Fig 6C) may be facilitated by enzymes including Pin1. Additionally, since the trans configuration is the more prevalent of the two isomers, Pin1 preferentially catalyses the formation of the cis isomer. The cis isomer is often not accessible to enzymes which bring about subsequent modifications including ubiquitination [19, 21] and de-phosphorylation [38] . Conversely, proteins may become more accessible to such alternations as a consequence of isomerisation which promotes the subsequent modification.
Therefore, Pin1 can act as a means of accelerating or delaying further processing of proteins [38] and has been shown to be a regulator of diverse mechanisms including cell cycle regulation [22, 23, [40] [41] [42] , receptor function [42] and protein stability [16, [22] [23] [24] .
In our study, the ability of Pin1 to alter the incorporation of TF into microvesicles was clearly reduced in a concentration-dependent manner, through deactivation of Pin1 with Juglone but not its non-inhibiting analogue, Plumbagin (Fig 1) . These two compounds differ by one methyl group and have similar activities in the cell except in the ability to deactivate Pin1 [44] [45] [46] . These data were also confirmed by the suppression of Pin1 expression using specific siRNA.
Interestingly, deactivation of Pin1, or the suppression of its expression did not alter the release of microvesicles. This is in agreement with our previous studies which suggest that the incorporation of TF into microvesicles, and the process of microvesicle release, are mediated through distinct and separate mechanisms [4] . Although ultimately, the outcome of these two mechanisms do overlap. Importantly, the ability of Pin1 to protect TF release appears to be through preserving the phosphorylation state of Ser253 within the cytoplasmic domain of TF (Fig 2) . The phosphorylation of this amino acid is required for the recruitment of filamin A which is essential for the incorporation of TF into microvesicles [9] [10] [11] .
Pin1 preferentially interacted with Ser258-phosphorylated TF peptide and to a lesser extend with the double-phosphorylated peptide, but had a much low affinity for the Ser253-phosphorylated peptide (Fig 3) . In addition, the inclusion of Pin1 into the in vitro phosphatase reaction, hindered the de-phosphorylation of the double-phosphorylated TF peptide by PP2Aα, but was not as effective in protecting the Ser253-phosphorylated peptide (Fig 5) . Together these findings suggest that following the phosphorylation of Ser258 within the cytoplasmic domain of TF, the formation of phospho-serine-proline epitope permits the interaction of Pin1 with doublephosphorylated TF. Since, the majority of TF is in the trans configuration, isomerisation by Pin1 favours the formation of the cis isomer. This form of TF is likely to be capable of interacting with filamin A and therefore be released, since ser253 is located on the adjacent side of the protein [5, 33] and is not directly affected. Moreover, the cis isomer appears to be less prone to dephosphorylation by PP2Aα. However, neither the trans or cis isomers of TF appeared to be ideal substrates for PP2Aα (Fig 5) . In contrast, the rate of TF de-phosphorylation was greatly enhanced following ubiquitination of TF. Importantly, Pin1 was capable of effectively disrupting the ubiquitination of TF peptide by the ubiquitin ligase complex (Fig 4C) as well as the dephosphorylation of the ubiquitinated peptide (5C). This was further supported by the suppression of Pin1 expression which resulted in accelerated ubiquitination of TF in cells ( Fig   4B) . Together, these observations suggest that the main mode of action of Pin1 is through the prevention of ubiquitination of the cytoplasmic domain of TF, which is essential for the rapid dephosphorylation of Ser253 within TF, by PP2Aα (Fig 7) . Consequently, it is possible that the cis isomer of TF may be incorporated and released into microvesicles unhindered. This is not in agreement with our previous report which indicated that endothelial-derived microvesicles do not contain double-phosphorylated TF [4] . Nonetheless, the concentration of Pin1 within normal primary cells was determined to be in the range of 19 nM. Therefore, it is likely that depending on the amount of TF being released, arising from the level of injury/trauma, cellular Pin1 may become saturated. As a result, a small amount of TF may become ubiquitinated, dephosphorylated and possibly endocytosed [6] . Since Ser258-phosphorylated TF appears to be the preferred substrate for Pin1 (Fig 3) , the sequestration of Pin1 to Ser258-phosphorylated TF further reduces the amount of available Pin1 (Fig 7) . Consequently, the reduction in the rate of isomerisation of double-phosphorylated TF would lead to the progressively accelerated TF ubiquitination and the abrupt termination of TF release. Therefore at least in normal cells, the majority of TF will be released in the Ser253-phposphorylated form and only a minor amount will be released in the double-phosphorylated form. This explains the lack of detectable phosphorylated Ser258 in endothelial cells as reported in our previous study [4] . Furthermore, it is interesting to note that tumour cells such as MDA-MB-231 cells often contain much higher levels of Pin1 (44.8 nM) which may reach concentrations of up to 500 nM in some cancer cells [39, [47] [48] [49] . This explains how these cells retain their ability to release TF at high rates even in the presence of augmented expression levels of TF. In addition, ubiquitinated receptors are often endocytosed through ubiquitin-dependent receptors [49] [50] [51] [52] [53] which explains how the mechanism of termination is effective in rodents, without the need for dephosphorylation of a serine residue which lacks in murine.
In conclusion, Pin1 is a fast acting enzyme capable of interacting with the cytoplasmic domain of TF and protecting this protein from ubiquitination and the subsequent dephosphorylation. Therefore, Pin1 acts as a gauge for the amount of TF being released by the cells and therefore functions to determine the level of injury incurred.
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